Ovid Therapeutics Inc. (OVID) Operating margin 2020–2025
Ovid Therapeutics Inc. (OVID) operating margin by fiscal year — reported operating income divided by reported revenue.
-585.2%FY2025 · since FY2020: -645.4% → -585.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -585.2% | +10348.5 pp |
| FY2024 | -10933.7% | +4189.0 pp |
| FY2023 | -15122.7% | -11426.3 pp |
| FY2022 | -3696.4% | -3756.0 pp |
| FY2021 | 59.6% | +705.0 pp |
| FY2020 | -645.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OVID financial trends
OVID RevenueOVID Net incomeOVID Net marginOVID Gross profitOVID Gross marginOVID Operating incomeOVID Operating cash flowOVID Free cash flowOVID Capital expendituresOVID Return on equityOVID Stock buybacksOVID Dividends paidOVID Total assetsOVID Total liabilitiesOVID Shareholders’ equityOVID overview →